Louis Allesandrine
Vice President
Oncology
Otsuka
Japan
Biography
As Vice President of Oncology Marketing and Sales at Otsuka America Pharmaceutical, Inc. (OAPI) I am responsible for leading the strategic development and execution of our U.S.-based commercial oncology business. This includes the co-promotion of SPRYCEL® (dasatinib) with BMS and our clinical stage collaborations with Astex Pharmaceuticals, a member of The Otsuka Group. Our goal is to develop and bring novel cancer therapeutics to market; meeting the needs of patients, their care givers and healthcare professionals. I joined OAPI in 2017 after 25 years of commercial experience in the pharmaceutical industry. Prior to joining OAPI, I served 6 years as Vice President, Oncology Marketing at Boehringer Ingelheim. Earlier in my career I held a series of leadership positions in sales and marketing focused in the areas of oncology and urology specialty care. I received an M.B.A. degree from Quinnipiac University.
Research Interest
Oncology
